Laparoscopic Surgery for T4 Tumor of the Colon Cancer (LST4C Trial)

Not Applicable

Recruiting

• Conditions: Colonic Neoplasms
• Interventions: Procedure: Laparoscopic surgery

• Registration Number: NCT03314896
• Lead Sponsor: LI XIN-XIANG

Brief Summary

The purpose of this study is to compare the short- and long-term survival of laparoscopic surgery and conventional open surgery for T4 colon cancer

Detailed Description

The investigators previous study indicated that laparoscopic surgery is feasible in T4 colon cancers with comparable clinical and oncologic outcomes. Laparoscopy can be considered as an alternative approach for T4 colon cancers with the advantage of faster recovery. However, the clinical value of laparoscopic surgery for T4 colon cancer was only validated in some retrospective study and some prospective study in single institute with small sample of patients. The aim of the present study is to compare the short-and long-term survival outcomes of laparoscopic surgery and conventional open surgery for T4 colon cancer as well as the mortality and the morbidity. The number of patients needed to get a 80% power is 1960. The average number of patients/surgical center is approximately 200 in each of 10 surgical centers. The preoperative, intraoperative and postoperative period will be in complete accordance with the usual care of the center. The baseline demographics and conditions as well as the perioperative items and the postoperative occurrences will be recorded through a prior designed equestionnaire.

Systematically analyze and compare the disease free survival rate, the mortality, the morbidity, and the proportion of completion of laparoscopic surgery of the two surgical strategies (laparoscopy VS conventional open surgery).

Study Timeline

• Study Start: 2016-10
• Study First Submitted: 2017-10-16
• Study First Submitted QC: 2017-10-16
• Study First Posted: 2017-10-19
• Status Verified: 2018-11
• Last Update Submitted: 2018-11-05
• Last Update Posted: 2018-11-06
• Primary Completion: 2019-10
• Study Completion: 2024-10

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 957

Inclusion Criteria

• Able to provide written informed consent

  • Histologically confirmed diagnosis of colon carcinoma
  • CT or MRI verified as T4 colon cancer without involvement of other organs
  • Without multiple lesion other than carcinoma in situ
  • Tumor size < 8 cm
  • No bowel obstruction
  • Sufficient organ function
  • No history of gastrointestinal surgery
  • 18 years of age or older
  • Performance Status (ECOG) 0, 1 or 2 and life expectancy > 12 weeks
  • Operable patients

Exclusion Criteria

• • Women who are pregnant (confirmed by serum b-HCG in women of reproductive age) or breast feeding

  • Unstable or uncompensated respiratory or cardiac disease
  • Serious active infections
  • Hypersensitivity to capecitabine/fluorouracil or oxaliplatin
  • Stomatitis, ulceration in the mouth or gastrointestinal tract
  • Severe diarrhea
  • Peripheral sensory neuropathy with functional impairment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Laparoscopic surgery for T4 colon tumor	Laparoscopic surgery	Laparoscopic surgery for T4 colon cancers

Primary Outcome Measures

Name	Time	Method
Overall survival	3-year	calculated from the date of diagnosis to the date of death from any cause

Secondary Outcome Measures

Name	Time	Method
Adverse events (mortality and morbidity)	3-month	Number of participants with treatment-related adverse events assessed by CTCAE v4.0
Disease free survival	3-year	calculated from the date of surgery to the date of recurrence

Trial Locations

Locations (1)

Fudan University Shanghai Cancer Center; 🇨🇳 Shanghai, Shanghai, China